PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Comprehensive Review

Volume 6 Issue 2

Revisiting the Role of Hysteroscopy in Infertility: A Clinical Perspective

Supriya Hajela* and Rajni Hajela

July 30, 2025

Abstract

Hysteroscopy is pivotal in assessing and managing intrauterine abnormalities that impact fertility. Although it is the gold standard for uterine cavity evaluation, it is often relegated to a secondary role due to its invasive nature and cost. This article provides a comprehensive review of the indications, benefits, and outcomes associated with hysteroscopy in infertility, focusing on recurrent implantation failure (RIF) and operative interventions. The review also integrates current evidence and global guidelines while emphasizing the need for individualized, evidence-based fertility care.

Keywords: Hysteroscopy; Infertility; Recurrent Implantation Failure; Polyps; Fibroids; Asherman’s Syndrome; Endometrial Receptivity; Dydrogesterone; ART

References

  1. Evans J., et al. “Fresh versus frozen embryo transfer: backing clinical decisions with scientific and clinical evidence”. Hum Reprod Update 20.6 (2014): 808-821.
  2. Norma O'Flynn. “Assessment and treatment for people with fertility problems: NICE guideline”. Br J Gen Pract 64.618 (2014): 50-1.
  3. Di Spiezio Sardo A., et al. “Efficacy of hysteroscopy in improving reproductive outcomes of infertile couples: a systematic review and meta-analysis”. Hum Reprod Update 22.4 (2016): 479-496.
  4. AAGL. “AAGL practice report: practice guidelines for the diagnosis and management of endometrial polyps”. J Minim Invasive Gynecol 19.1 (2012): 3-10.
  5. Yanaihara A., et al. “Location of endometrial polyp and pregnancy rate in infertility patients”. Fertil Steril 90 (2008): 180-182.
  6. Taylor E and Gomel V. “The uterus and fertility”. Fertil Steril 89.1 (2008): 1-16.
  7. Hanstede MMF., et al. “Results of centralized Asherman surgery, 2003-2013”. Fertil Steril 104.6 (2015): 1561-1568.e1.
  8. Motak-Pochrzest H., et al. “Does autoimmunity play a role in the risk of implantation failures?”. Neuro Endocrinol Lett 38.8 (2018): 575-578.
  9. Simon A., et al. “Assessment and treatment of repeated implantation failure (RIF)”. J Assist Reprod Genet 29.11 (2012): 1227-1239.
  10. Griesinger G., et al. “Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial”. Hum Reprod 33.12 (2018): 2212-2221.
  11. Potdar N., et al. “Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis”. Hum Reprod Update 19.6 (2013): 674-684.
  12. Nakagawa K., et al. “Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios”. Am J Reprod Immunol 73.4 (2015): 353-361.
  13. Cicinelli E., et al. “Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy”. Hum Reprod 30.2 (2015): 323-330.
  14. Von Wolff M., et al. “Thin Endometrium Is Also Associated With Lower Clinical Pregnancy Rate in Unstimulated Menstrual Cycles: A Study Based on Natural Cycle IVF”. Front Endocrinol (Lausanne) 9 (2018): 776.
  15. Franasiak JM., et al. Springer Int Publ (2018).
  16. Acharya KS., et al. “Freezing of all embryos in in vitro fertilization is beneficial in high responders, but not intermediate and low responders: an analysis of 82,935 cycles from the Society for Assisted Reproductive Technology registry”. Fertil Steril 110.5 (2018): 880-887.
  17. Coates A., et al. “Optimal euploid embryo transfer strategy, fresh versus frozen, after preimplantation genetic screening with next generation sequencing: a randomized controlled trial”. Fertil Steril 107.3 (2017): 723-730.
  18. Raghupathy R., et al. “Modulation of Cytokine Production by the Dydrogesterone Metabolite Dihydrodydrogesterone”. Am J Reprod Immunol 74.5 (2015): 419-426.
  19. Zamaniyan M., et al. “Effect of platelet-rich plasma on pregnancy outcomes in infertile women with recurrent implantation failure: a randomized controlled trial”. Gynecol Endocrinol 37.2 (2021): 141-145.